Preclinical News and Research

RSS
NanoViricides files FluCide pre-IND briefing document with the FDA

NanoViricides files FluCide pre-IND briefing document with the FDA

Dana-Farber receives MLSC grant to expand cancer imaging research

Dana-Farber receives MLSC grant to expand cancer imaging research

CartiHeal secures $5M in venture funding

CartiHeal secures $5M in venture funding

Scientists identify TDO enzyme as new target for cancer therapy

Scientists identify TDO enzyme as new target for cancer therapy

New combination clinical trial may improve outcome for cancer surgery patients

New combination clinical trial may improve outcome for cancer surgery patients

Milestone for Starpharma's drug delivery program

Milestone for Starpharma's drug delivery program

Breast cancer survivors use at-home method to prep their breasts for reconstruction

Breast cancer survivors use at-home method to prep their breasts for reconstruction

For stroke prevention, large medical centers may have the edge

For stroke prevention, large medical centers may have the edge

KineMed, Pfizer enter research collaboration on metabolic diseases

KineMed, Pfizer enter research collaboration on metabolic diseases

Circadian's VGX-100 human antibody improves corneal graft survival

Circadian's VGX-100 human antibody improves corneal graft survival

Susan Mallery finds breakthrough treatment for oral cancer

Susan Mallery finds breakthrough treatment for oral cancer

Scientists develop new vaccine to treat cancer at pre-clinical level

Scientists develop new vaccine to treat cancer at pre-clinical level

Scientists evaluate growth, differentiation and function of iPSC-derived NPCs in PD

Scientists evaluate growth, differentiation and function of iPSC-derived NPCs in PD

Prosensa secures €23M in new equity financing

Prosensa secures €23M in new equity financing

Cohera receives FDA IDE approval to initiate U.S. clinical study for TissuGlu

Cohera receives FDA IDE approval to initiate U.S. clinical study for TissuGlu

GUMC licenses worldwide rights of 'theranostic' to BioMetrx

GUMC licenses worldwide rights of 'theranostic' to BioMetrx

Sofie to receive U.S. patent for novel PET probes

Sofie to receive U.S. patent for novel PET probes

Aphios receives NIH's Phase II SBIR grant to develop APH-0703 for AD

Aphios receives NIH's Phase II SBIR grant to develop APH-0703 for AD

Genoscience, BioLineRx to develop and commercialize BL-8020 for HCV

Genoscience, BioLineRx to develop and commercialize BL-8020 for HCV

Younger breast cancer survivors face more serious mental issues

Younger breast cancer survivors face more serious mental issues

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.